Editorial: Much ado about nothing

Which brings us to the third question the White Paper raises, one that, no matter how often we listen to them, the conventional answers never seems to allay a certain kind of puzzlement. While the medicine prescribed by AmCham is regarded as the way forward for all wannabe rich economies, Italy shows us that you can get rich by ignoring almost every guideline in the textbook. So does any of this really matter?